PSA Today Dec 23: Reflective day / Mixed set of news for Japan pharma / Square Enix best week on mobile / NTT Data subsidiary still struggling / Christmas comes early for Cybozu / Oracle Japan's FY19 Q2 results – Nikkei +0.02%
Japan Market Comment by Pelham Smithers and Lindsay WhippNikkei ¥23,821.11 (+¥4.48 / +0.02%); Topix ¥1,729.42 (-¥3.65/ -0.21%); ¥/$109.43
Tags: TDK (6762 JT), Murata (6981 JT), Alps Alpine (6770 JT), Daiichi Sankyo (4568 JT), Eisai (4523 JT), Shionogi (4507 JT), Takeda Pharmaceutical (4502 JT), Square Enix (9684 JT), Colopl (3668 JT), NTT Data (9613 JT), Cybozu (4776 JT), Oracle Japan (4716 JT), Obic (4684 JT)
Main Points
• Market slides as investors weigh whether recent rally justified
• Mixed set of news for Japan pharma
• Square Enix has best week on mobile
• NTT Data subsidiary still struggling to fully recover data from cloud storage failure
• Christmas comes early for Cybozu
• Oracle Japan produces steady FY19 Q2
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.